Xeris Pharmaceuticals | XERS - 市值



金融业
股票价格
USD
资产
USD 411.91M
现金及等价物
USD 121.75M
销售成本
USD 10.57M
流动资产
USD 274.76M
流动负债
USD 189.57M
债务
USD 258.55M
EBIT
USD 9.12M
EBITDA
USD 12.33M
员工
377
EPS每股收益
USD 0.01
股本和储备
USD -9.73M
销售毛利
USD 72.55M
债务利息支出
USD 6.88M
利息收入
USD 1.2M
贷款资金
USD 188.81M
市值
USD 1.08B
净收入
USD 2.23M
营业费用
USD 75.21M
营业利润
USD 7.92M
普通股股本
USD 172.56M
PE价格收益
76.05
税前利润
USD 2.23M
销售收入
USD 83.13M
销售和管理费用
USD 53.14M
股票
USD 80.93M
贸易债权人
USD 9.34M
应收帐款人
USD 56.3M


市值 更改 日
Cspc Pharmaceutical CNY 103.79B 16.5B 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Divis Laboratories Ltd INR 1.75T 167.78B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 62.53M 563.29K 2025-12
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 252.47M 59.69M 2026-03
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pacira USD 998M 83M 2026-06
Pharma Mar EUR 1.31B 263.2M 2026-06
Qiagen NV USD 8.07B 197.36M 2026-06
Sartorius EUR 15.63B 1.38B 2026-06
Supernus Pharmaceuticals USD 2.7B 277M 2026-06
Zealand Pharma A/S 20.84B 12.51B 2026-03
Zz Pientze Pharmaceu CNY 65.93B 25.23B 2026-06